New Frontier Magazine

Biotechnology

9 articles

AI energy neutralizing respiratory viruses, with logos of Stripe, OpenAI, and Anthropic symbolizing a collaborative fight against disease.
Artificial Intelligence

Stripe, Anthropic, OpenAI Launch $500M Fund to Fight Respiratory Infections

Stripe, Anthropic, and OpenAI lead a coalition of backers, including Flu Lab, the OpenAI Foundation, Bill Gates, and Jane Street Capital traders, in Intercept: a new $500 million fund aiming to elimin

Dr. Aris Thorne·June 25, 2026
Microscopic view of human skin cells showing rejuvenated cellular structures, illuminated by soft, glowing light trails indicating the reversal of aging markers.
Biotech & Health

Cellular reprogramming reverses aging markers in lab

Scientists recently reversed cellular aging markers in human skin cells by 30 years in a lab dish.

Juliana Campos·June 13, 2026
AI algorithms analyzing molecular structures in a futuristic lab, visualizing human rejuvenation and healthspan extension.
Biotech & Health

AI Accelerates Whole Body Rejuvenation Drug Discovery for Healthspan

David Sinclair plans to launch human tests of an oral 'reprogramming' drug as part of a $101 million XPrize competition, according to MIT Technology Review .

Lena Petrova·June 10, 2026
Advanced laboratory equipment and a visual representation of cellular regeneration, symbolizing a new era in aging research and rejuvenation therapies.
Biotech & Health

David Sinclair's Company Gets FDA Nod for Rejuvenation Trial

Life Biosciences, co-founded by prominent longevity researcher David Sinclair, has received FDA approval to begin the first human trial for a 'rejuvenation treatment' called ER-100.

Lena Petrova·June 9, 2026
Close-up cinematic view of CRISPR-Cas9 molecular scissors precisely editing a glowing DNA helix in a futuristic laboratory.
Biotech & Health

How CRISPR Gene Editing Technology Works Explained

CRISPR–Cas9 and related technologies have successfully cured life-threatening diseases, created coronavirus detection tests, and modified human embryo cells, according to crispr-cas systems: overview,

Juliana Campos·June 8, 2026
A scientist working with advanced AI interfaces and holographic displays in a futuristic pharmaceutical lab, representing AI's role in drug discovery.
Biotech & Health

How AI is Transforming Pharma Discovery and Development by 2034

In just five years, regulatory submissions containing AI/ML components in the pharmaceutical industry surged from 1 in 2016 to 132 in 2021, according to pmc .

Juliana Campos·June 7, 2026
Medical professionals in hazmat suits working in a tense, dimly lit clinic during an Ebola outbreak in a conflict zone.
Biotech & Health

Ebola outbreak control challenges mount with Bundibugyo species spread

The current Ebola outbreak in the Democratic Republic of the Congo and Uganda silently spread for weeks before a nurse, the first known case, developed symptoms on April 24, according to BBC .

Juliana Campos·May 30, 2026
Advanced AI interface in a futuristic medical lab assisting doctors in early disease detection, showcasing the synergy between technology and human expertise.
Biotech & Health

Roche Acquires PathAI, Betting Big on AI Early Disease Detection

Roche is set to acquire PathAI for an upfront payment of $750 million, with potential milestone payments pushing the total past $1 billion, The Wall Street Journal reports.

Juliana Campos·May 18, 2026
Scientists in a futuristic lab working with glowing DNA helixes, symbolizing the revolutionary potential of CRISPR gene editing in medicine.
Biotech & Health

How CRISPR Gene Editing Works: Revolutionizing Medicine

In a groundbreaking clinical trial, 29 out of 31 patients treated with Casgevy for sickle cell disease were freed from severe pain for at least a year.

Lena Petrova·May 15, 2026